Achaogen: Achaogen Inc. Announces Results of Auction for Substantially All Company Assets
SOUTH SAN FRANCISCO Calif. June 06 2019 GLOBE NEWSWIRE &8212; Achaogen Inc. a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multidrug resistant MDR gramnegative infections announced today it has rea...
Read full article »
Achaogen develops and commercializes novel antibacterials to treat the multi-drug resistant gram-negative infections.
Read more